No abstract available
Keywords:
Cross-transmission; Transmission croisée; Tuberculose XDR; XDR-tuberculosis.
MeSH terms
-
Adalimumab / adverse effects
-
Adalimumab / therapeutic use
-
Adult
-
Community-Acquired Infections / diagnosis
-
Community-Acquired Infections / transmission*
-
Contact Tracing*
-
Cross Infection / diagnosis
-
Cross Infection / prevention & control
-
Diagnosis, Differential
-
Disease Progression
-
Extensively Drug-Resistant Tuberculosis / epidemiology
-
Extensively Drug-Resistant Tuberculosis / prevention & control
-
Extensively Drug-Resistant Tuberculosis / transmission*
-
France / epidemiology
-
Georgia (Republic) / ethnology
-
Hospital Departments
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Infectious Disease Medicine
-
Male
-
Patient Compliance*
-
Patient Isolation*
-
Spondylitis, Ankylosing / complications
-
Tuberculosis, Hepatic / microbiology
-
Tuberculosis, Lymph Node / microbiology
Substances
-
Immunosuppressive Agents
-
Adalimumab